Clinical Trial Update: Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone [NA]

View source ↗

Summary

A completed clinical trial evaluating a personalised approach to tapering corticosteroid doses in systemic lupus erythematosus patients treated with prednisone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Lupus Erythematosus, Systemic | NA | Status: COMPLETED